Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog) After Ingestion of a Standardized Meal

Trial Profile

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog) After Ingestion of a Standardized Meal

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Adocia

Most Recent Events

  • 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
  • 16 Sep 2016 Results assessing ultra-rapid pharmacokinetic characteristics of BioChaperone Lispro, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
  • 06 Jun 2016 Results will be presented at the American Diabetes Association 76th Scientific Sessions 2016, according to an Adocia media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top